论文部分内容阅读
我们继前报道了(β-CDBA β-环糊精苯甲醛)新剂型抗癌药物的制备后,又进行了该药的药效学的初步实验。本文仅从动物实验方面的疗效差异,根据β-CDBA的化学结构和合成的制剂的原料不同,即它们的构效关系进行评估。分别用1％的苯甲醛和无花果提取液(苯甲醛含
We have previously reported (β-CDBA β-cyclodextrin benzaldehyde) a new type of anticancer drug preparation, but also conducted a preliminary pharmacodynamics of the drug. This article only from the differences in the efficacy of animal experiments, based on the chemical structure of β-CDBA and synthetic raw materials, that is, their structure-activity relationship assessment. Respectively with 1% benzaldehyde and fig extract (benzaldehyde containing